Navigating the Latest Evidence and Strategies for Renal Risk Reduction in T2D

Content Format:

Text Module

Credit Type:

AAPA | AMA | ANCC

Credits:

1.00
Integrating GLP-1 RAs Into T2D and CKD Management

Content Format:

Video

Credit Type:

AAPA | AMA | ANCC

Credits:

0.50
Challenges and Clinical Evidence in T2D and CKD Management

Content Format:

Video

Credit Type:

AAPA | AMA | ANCC

Credits:

0.50
Reducing Renal Risk in Patients with Type 2 Diabetes

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Navigating the Latest Evidence and Strategies for Renal Risk Reduction in T2D

Content Format:

Slideset

Credit Type:

--

Credits:

--
Addressing the Buzz Around Incretin-Based Therapies With Patients

Content Format:

Clinical Thought

Credit Type:

ABIM MOC | AMA

Credits:

0.25
Breaking Down the Headlines: Addressing the Buzz Around Incretin-Based Therapies With Patients

Content Format:

Podcast Episodes

Credit Type:

--

Credits:

--
Integrating the Latest Treatments for T2D Into Patient Care: Connecting Mechanism of Action to Clinical Evidence

Content Format:

Video

Credit Type:

ABIM MOC | AMA

Credits:

0.50
Integrating the Latest Treatments for T2D Into Patient Care: Connecting Mechanism of Action to Patient Cases

Content Format:

Video

Credit Type:

ABIM MOC | AMA

Credits:

0.50
Integrating the Latest Treatments for T2D Into Patient Care: Connecting Mechanism of Action to Patient Cases

Content Format:

Slideset

Credit Type:

--

Credits:

--
Integrating the Latest Treatments for T2D Into Patient Care: Connecting Mechanism of Action to Clinical Evidence

Content Format:

Slideset

Credit Type:

--

Credits:

--
Integrating the Latest Treatments for T2D Into Patient Care: Connecting Mechanism of Action to Physiologic Actions

Content Format:

Video

Credit Type:

ABIM MOC | AMA

Credits:

0.50
Integrating the Latest Treatments for T2D Into Patient Care: Connecting Mechanism of Action to Physiologic Actions

Content Format:

Slideset

Credit Type:

--

Credits:

--
Strategies for Clinical Success With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and GIP/GLP-1 Coagonists

Content Format:

Clinical Thought

Credit Type:

ABIM MOC | AMA

Credits:

0.25
You and Type 2 Diabetes: Why Does Weight Loss Matter?

Content Format:

PDF

Credit Type:

--

Credits:

--
Optimizing Management of Patients With Cardiometabolic and Renal Disease: A Case-Based Multidisciplinary Discussion

Content Format:

PCE On Demand Live Presentation

Credit Type:

AAPA | ANCC

Credits:

1.00
Optimizing Management of Patients With Cardiometabolic and Renal Disease: A Case-Based Multidisciplinary Discussion

Content Format:

Slideset

Credit Type:

--

Credits:

--
Tips on Prescribing SGLT2 Inhibitors in Diabetic Kidney Disease

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Role of SGLT2 Inhibitors in Type 2 Diabetes With Chronic Kidney Disease

Content Format:

Multimedia

Credit Type:

AMA | ANCC

Credits:

0.25
Role of SGLT2 Inhibitors in Type 2 Diabetes With Chronic Kidney Disease

Content Format:

Slideset Download

Credit Type:

--

Credits:

--